business / news / / Business Today
Counterfeit versions of Keytruda, a blockbuster cancer immunotherapy, have been detected in multiple markets, including in India-linked supply chains.
Counterfeit Keytruda has been detected in India-linked supply chains before biosimilars are legally available.
KEY POINTS
- WHO issued a global alert in November 2024 warning falsified Keytruda poses significant public health risks.
- US authorities sentenced an Indian national in March 2024 for trafficking counterfeit Keytruda with no active ingredient.
- Indian drug regulators have increased surveillance and batch testing in response to global counterfeit alerts.
- Counterfeit oncology drugs are entering markets before patent expiry, mirroring trends seen with Ozempic.
COMPANIES
Summarized by Newsio from Business Today. How we summarize →